NO20006320D0 - Cyclic somatostatin analogues - Google Patents

Cyclic somatostatin analogues

Info

Publication number
NO20006320D0
NO20006320D0 NO20006320A NO20006320A NO20006320D0 NO 20006320 D0 NO20006320 D0 NO 20006320D0 NO 20006320 A NO20006320 A NO 20006320A NO 20006320 A NO20006320 A NO 20006320A NO 20006320 D0 NO20006320 D0 NO 20006320D0
Authority
NO
Norway
Prior art keywords
somatostatin analogues
cyclic somatostatin
cyclic
analogues
somatostatin
Prior art date
Application number
NO20006320A
Other languages
Norwegian (no)
Other versions
NO20006320L (en
Inventor
Thomas D Gordon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20006320D0 publication Critical patent/NO20006320D0/en
Publication of NO20006320L publication Critical patent/NO20006320L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20006320A 1998-06-16 2000-12-12 Cyclic somatostatin analogues NO20006320L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9818198A 1998-06-16 1998-06-16
US8950398P 1998-06-16 1998-06-16
PCT/US1999/013304 WO1999065942A1 (en) 1998-06-16 1999-06-11 Cyclic somatostatin analogs

Publications (2)

Publication Number Publication Date
NO20006320D0 true NO20006320D0 (en) 2000-12-12
NO20006320L NO20006320L (en) 2001-02-12

Family

ID=26780645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006320A NO20006320L (en) 1998-06-16 2000-12-12 Cyclic somatostatin analogues

Country Status (12)

Country Link
EP (1) EP1086131A1 (en)
JP (1) JP2002518409A (en)
CN (1) CN1200000C (en)
AR (1) AR021161A1 (en)
AU (1) AU745493B2 (en)
CA (1) CA2335184A1 (en)
HU (1) HUP0102902A3 (en)
NO (1) NO20006320L (en)
PL (1) PL345037A1 (en)
RU (1) RU2242481C2 (en)
TW (3) TW527361B (en)
WO (1) WO1999065942A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0202648A3 (en) 1998-06-12 2003-02-28 Sod Conseils Rech Applic Imidazolyl derivatives, pharmaceutical compositions containing them and their use
FR2796945B1 (en) 1999-07-30 2002-06-28 Sod Conseils Rech Applic NOVEL DERIVATIVES OF HYDANTOINS, THIOHYDANTOINS, PYRIMIDINEDIONES AND THIOXOPYRIMIDINONES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
US7566734B2 (en) * 2000-08-01 2009-07-28 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
US8017575B2 (en) 2004-12-15 2011-09-13 Wilfred Wayne Lautt Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
JP5225098B2 (en) 2005-12-14 2013-07-03 ブリストル−マイヤーズ スクイブ カンパニー Arylpropionamide, arylacrylamide, arylpropinamide, or arylmethylurea analogs as factor XIa inhibitors
ES2365815T3 (en) * 2005-12-14 2011-10-11 Bristol-Myers Squibb Company ANALOGS OF ARILPROPIONAMIDA, ARILACRILAMIDA, ARILPROPINAMIDA OR ARILMETILUREA AS INHIBITORS OF THE XIA FACTOR.
PE20110480A1 (en) 2008-09-26 2011-07-01 Ambrx Inc MICROORGANISMS AND VACCINES DEPENDENT ON REPLICATION OF NON-NATURAL AMINO ACIDS
EP2168983A1 (en) * 2008-09-30 2010-03-31 Ipsen Pharma New octapeptide compounds and their therapeutic use
JP5535931B2 (en) * 2008-10-27 2014-07-02 武田薬品工業株式会社 Bicyclic compound
AU2017217271C1 (en) * 2016-02-09 2021-08-05 Cdrd Ventures Inc. Somatostatin receptor antagonist compounds and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
GB9513224D0 (en) * 1995-06-29 1995-09-06 Sandoz Ltd Organic compounds
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
CN1305496A (en) 2001-07-25
TWI242441B (en) 2005-11-01
HUP0102902A3 (en) 2002-02-28
JP2002518409A (en) 2002-06-25
HUP0102902A2 (en) 2002-01-28
TW200410986A (en) 2004-07-01
CA2335184A1 (en) 1999-12-23
AR021161A1 (en) 2002-07-03
TW527361B (en) 2003-04-11
CN1200000C (en) 2005-05-04
PL345037A1 (en) 2001-11-19
AU4822399A (en) 2000-01-05
WO1999065942A8 (en) 2000-02-17
WO1999065942A1 (en) 1999-12-23
NO20006320L (en) 2001-02-12
RU2242481C2 (en) 2004-12-20
EP1086131A1 (en) 2001-03-28
TWI242442B (en) 2005-11-01
AU745493B2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
DK1307486T3 (en) somatostatin analogues
DE69905038D1 (en) CYCLIC BOROPROLIN COMPOUNDS
DK1124779T3 (en) Vitamin D analogues
EP1353683A4 (en) GHRELINE ANALOGS
DE69922494D1 (en) CYCLIC N-ACYLAMINE DERIVATIVES
DK1070058T3 (en) (4-Arylsulfonylamino) tetrahydropyran-4-carboxylsyrehydroxamider
DE69941708D1 (en) PACAP PEPTIDE ANALOGS
NL300344I1 (en) Nucleotide analogues
DE69730151D1 (en) CYCLIC SULPHON DERIVATIVES
DE69931076D1 (en) HARDENABLE MIXTURES
ID29066A (en) FENILGLISINA DOWN
ID27423A (en) KUINOLIN DOWN
DE59909594D1 (en) SCHNULLER SUCKER
DE69839978D1 (en) Fluoropolymer stabilization
ID23234A (en) BENZOSULFONA DOWN
NO996252L (en) Ettborings risers
ATA153698A (en) HANDRAIL
EP0996458A4 (en) SANDRAMYCIN ANALOGS
FI980516A7 (en) Verified connection arrangement
DE59912137D1 (en) encoders
PL345037A1 (en) Cyclic somatostatin analogs
FR2780445B1 (en) TURBO
FI980268A0 (en) Foerfarande Foer framstaellning av cyclic monomerer
DE69913220D1 (en) Cyclic bis-phosphites
NO995788D0 (en) Workstations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application